Enrolling
Women and Girls
Prevention (PREV)
Filter By:
Reporting
CTN 308: Estrogen and Probiotic Treatment for Vaginal Health
Improving vaginal health to decrease biological risk of HIV-1 infection in Canadian ACB women
Learn MoreReporting
CTN 307: ECF/TAF Switch in opioid substitution therapy
Evaluation of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (ECF/TAF) Switch followed by Sofosbuvir/Velpatasvir (SOF/VEL) Antiviral HCV Therapy in HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy — A Pilot Feasibility Study
Learn MoreStart-up
CTN 303: Decentralizing PrEP
Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses
Learn MoreCompleted
CTN 302: Visioning Health II
Indigenous, participatory evaluation and assessment of a culturally-grounded and arts-informed intervention for HIV-positive Aboriginal women
Learn MoreStart-up
CTN 301-2: DRUM and SASH Urban-Rural Sub-Study
Contextual Analysis of Urban and Rural Programs and Supports for First Nations and Métis People Living with HIV and other STBBIs
Learn MoreReporting
CTN 301: DRUM
Development of a Rural Model (DRUM) for Integrated Shared Care in First Nation and Métis Communities
Learn MoreOngoing
CTN 300: The Engage Cohort Study
HIV Prevention for Gay, Bisexual, and other Men Who Have Sex with Men
Learn MoreCompleted
CTN 299: BEING-W
BonE health in ageING Women: improvement or prevention of changes in bone mineral density by switching antiretroviral agents
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.